Prolongation and enhancement of serum methotrexate concentrations by probenecid.
The disappearance of methotrexate (MTX) from the serum after an intravenous bolus injection and intravenous infusion was studied over 24 hours in eight and four patients respectively. Probenecid given at the same time as the bolus injection delayed the disappearance of MTX from the serum and resulted in enhanced concentrations throughout the 24 hours studied. At 24 hours the mean concentration was four times higher than in patients not given probenecid. Overall serum concentrations were even greater than those in patients who had received MTX by intravenous infusion. We suggest that smaller doses of MTX may be given and treatment costs thereby reduced if probenecid is given in addition.
D000328:Adult; D000368:Aged; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000097:blood*; D008875:Middle Aged; D011339:Probenecid / Q000494:pharmacology*
D011339:Probenecid; D008727:Methotrexate